Announcements Trials

Browse Landscape

Phase

Phase NA 13 Phase 2 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1 Breast 1

Conditions

Triple Negative Breast Neoplasms 1

Interventions

Trastuzumab 347 Paclitaxel 309 Cyclophosphamide 286 Docetaxel 267 Carboplatin 215 Capecitabine 214 Letrozole 185 Fulvestrant 176 Doxorubicin 166 Bevacizumab 136 Anastrozole 120 Tamoxifen 117 pertuzumab 112 pembrolizumab 112 Epirubicin 110 exemestane 107 Vinorelbine 106 Gemcitabine 106 Albumin-Bound Paclitaxel 92 Lapatinib 84 130-nm albumin-bound paclitaxel 83 Radiotherapy 79 palbociclib 75 eribulin 73 Cisplatin 69 pyrotinib 65 Taxes 65 Everolimus 55 Goserelin 50 Drug Therapy 50

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Exercise Therapy × Breast × Clear all

NCT06831955 2026-03-20

LESLIE

Universitaire Ziekenhuizen KU Leuven

Phase 2 Recruiting

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡